Literature DB >> 35322416

1,25-Dihydroxyvitamin D3 suppresses CD4+ T-cell effector functionality by inhibition of glycolysis.

Emma L Bishop1, Nancy H Gudgeon1, Gillian M Mackie1, Daniel Chauss2, Jennie Roberts3, Daniel A Tennant3, Kendle M Maslowski1,3, Behdad Afzali2, Martin Hewison3, Sarah Dimeloe1,3.   

Abstract

In CD4+ T helper cells, the active form of vitamin D3 , 1,25-dihydroxyvitamin D3 (1,25D) suppresses production of inflammatory cytokines, including interferon-gamma (IFN-γ), but the mechanisms for this are not yet fully defined. In innate immune cells, response to 1,25D has been linked to metabolic reprogramming. It is unclear whether 1,25D has similar effects on CD4+ T cells, although it is known that antigen stimulation of these cells promotes an anabolic metabolic phenotype, characterized by high rates of aerobic glycolysis to support clonal expansion and effector cytokine expression. Here, we performed in-depth analysis of metabolic capacity and pathway usage, employing extracellular flux and stable isotope-based tracing approaches, in CD4+ T cells treated with 1,25D. We report that 1,25D significantly decreases rates of aerobic glycolysis in activated CD4+ T cells, whilst exerting a lesser effect on mitochondrial glucose oxidation. This is associated with transcriptional repression of Myc, but not repression of mTOR activity under these conditions. Consistent with the modest effect of 1,25D on mitochondrial activity, it also did not impact CD4+ T-cell mitochondrial mass or membrane potential. Finally, we demonstrate that inhibition of aerobic glycolysis by 1,25D substantially contributes to its immune-regulatory capacity in CD4+ T cells, since the suppression of IFN-γ expression was significantly blunted in the absence of aerobic glycolysis. 1,25-Dihydroxyvitamin D3 (1,25D) suppresses the production of inflammatory cytokines such as interferon-gamma (IFN-γ) by CD4+ T cells, but the underpinning mechanisms are not yet fully defined. Here, we identify that 1,25D inhibits aerobic glycolysis in activated CD4+ T cells, associated with decreased c-Myc expression. This mechanism appears to substantially contribute to the suppression of IFN-γ by 1,25D, since this is significantly blunted in the absence of aerobic glycolysis.
© 2022 The Authors. Immunology published by John Wiley & Sons Ltd.

Entities:  

Keywords:  T cell; glycolysis; immunometabolism; metabolism; vitamin D

Mesh:

Substances:

Year:  2022        PMID: 35322416      PMCID: PMC9232967          DOI: 10.1111/imm.13472

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.215


  36 in total

Review 1.  Vitamin D regulates macrophage cholesterol metabolism in diabetes.

Authors:  Amy E Riek; Jisu Oh; Carlos Bernal-Mizrachi
Journal:  J Steroid Biochem Mol Biol       Date:  2010-03-23       Impact factor: 4.292

2.  Vitamin D3 Induces Tolerance in Human Dendritic Cells by Activation of Intracellular Metabolic Pathways.

Authors:  Gabriela Bomfim Ferreira; An-Sofie Vanherwegen; Guy Eelen; Ana Carolina Fierro Gutiérrez; Leentje Van Lommel; Kathleen Marchal; Lieve Verlinden; Annemieke Verstuyf; Tatiane Nogueira; Maria Georgiadou; Frans Schuit; Décio L Eizirik; Conny Gysemans; Peter Carmeliet; Lut Overbergh; Chantal Mathieu
Journal:  Cell Rep       Date:  2015-02-07       Impact factor: 9.423

3.  Tumor-derived TGF-β inhibits mitochondrial respiration to suppress IFN-γ production by human CD4+ T cells.

Authors:  Sarah Dimeloe; Patrick Gubser; Jordan Loeliger; Corina Frick; Leyla Develioglu; Marco Fischer; Florian Marquardsen; Glenn R Bantug; Daniela Thommen; Yannic Lecoultre; Alfred Zippelius; Anja Langenkamp; Christoph Hess
Journal:  Sci Signal       Date:  2019-09-17       Impact factor: 8.192

4.  1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A.

Authors:  Sneha Joshi; Luiz-Carlos Pantalena; Xikui K Liu; Sarah L Gaffen; Hong Liu; Christine Rohowsky-Kochan; Kenji Ichiyama; Akihiko Yoshimura; Lawrence Steinman; Sylvia Christakos; Sawsan Youssef
Journal:  Mol Cell Biol       Date:  2011-07-11       Impact factor: 4.272

5.  Vitamin D controls the capacity of human dendritic cells to induce functional regulatory T cells by regulation of glucose metabolism.

Authors:  An-Sofie Vanherwegen; Guy Eelen; Gabriela Bomfim Ferreira; Bart Ghesquière; Dana Paulina Cook; Tanja Nikolic; Bart Roep; Peter Carmeliet; Sucheta Telang; Chantal Mathieu; Conny Gysemans
Journal:  J Steroid Biochem Mol Biol       Date:  2018-11-24       Impact factor: 4.292

6.  1,25(OH)2D3 regulates c-myc mRNA levels in tonsillar T lymphocytes.

Authors:  R Karmali; M Hewison; N Rayment; S M Farrow; A Brennan; D R Katz; J L O'Riordan
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

7.  1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3.

Authors:  Louisa E Jeffery; Fiona Burke; Manuela Mura; Yong Zheng; Omar S Qureshi; Martin Hewison; Lucy S K Walker; David A Lammas; Karim Raza; David M Sansom
Journal:  J Immunol       Date:  2009-11-01       Impact factor: 5.422

Review 8.  Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential.

Authors:  Wendy Dankers; Edgar M Colin; Jan Piet van Hamburg; Erik Lubberts
Journal:  Front Immunol       Date:  2017-01-20       Impact factor: 7.561

9.  Differential Regulation of Human Treg and Th17 Cells by Fatty Acid Synthesis and Glycolysis.

Authors:  Deborah Cluxton; Andreea Petrasca; Barry Moran; Jean M Fletcher
Journal:  Front Immunol       Date:  2019-02-04       Impact factor: 7.561

10.  Availability of 25-hydroxyvitamin D(3) to APCs controls the balance between regulatory and inflammatory T cell responses.

Authors:  Louisa E Jeffery; Alice M Wood; Omar S Qureshi; Tie Zheng Hou; David Gardner; Zoe Briggs; Satdip Kaur; Karim Raza; David M Sansom
Journal:  J Immunol       Date:  2012-10-19       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.